Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/34600
Title: | Real‐life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA | Authors: | Seys, Sven F. De Bont, Shana Fokkens, Wytske J. Bachert, Claus Alobid, Isam Bernal‐Sprekelsen, Manuel Bjermer, Leif CALLEBAUT, Ina Cardell, Lars‐Olaf Carrie, Sean Castelnuovo, Paolo Cathcart, Russell Constantinidis, Jannis Cools, Leen Cornet, Marjolein Clement, Gregory COX, Tony Delsupehe, Lieve Correia‐de‐Sousa, Jaime Deneyer, Lauren De Vos, Geert Diamant, Zuzana Doulaptsi, Maria Gane, Simon Gevaert, Philippe Hopkins, Claire Hox, Valérie Hummel, Thomas Hosemann, Werner Jacobs, Raf Jorissen, Mark Kjeldsen, Anette Landis, Basile N. LEMMENS, Winde Leunig, Andreas Lund, Valerie Mariën, Gert Mullol, Joaquim Onerci, Metin Palkonen, Susanna Proano, Isabel Prokopakis, Emmanuel Ryan, Dermot Riechelmann, Herbert Sahlstrand‐Johnson, Pernilla Salmi‐Toppila, Sanna Segboer, Christine Speleman, Kato Steinsvik, Andreas Surda, Pavol Tomazic, Peter‐Valentin Vanderveken, Olivier Van Gerven, Laura Van Zele, Thibaut Verfaillie, Jan Verhaeghe, Benedicte Vierstraete, Kathie Vlaminck, Stephan Wagenmann, Martin Pugin, Benoit Hellings, Peter W. |
Issue Date: | 2020 | Source: | Allergy (Copenhagen), 75 (11) , p. 2867 -2878 | Abstract: | Background Chronic rhinosinusitis (CRS) is a chronic inflammatory disease associated with a substantial personal and socioeconomic burden. Monitoring of patient-reported outcomes by mobile technology offers the possibility to better understand real-life burden of CRS. Methods This study reports on the cross-sectional evaluation of data of 626 users of mySinusitisCoach (mSC), a mobile application for CRS patients. Patient characteristics of mSC users were analysed as well as the level of disease control based on VAS global rhinosinusitis symptom score and adapted EPOS criteria. Results The mSC cohort represents a heterogeneous group of CRS patients with a diverse pattern of major symptoms. Approximately half of patients reported nasal polyps. 47.3% of all CRS patients were uncontrolled based on evaluation of VAS global rhinosinusitis symptom score compared to 40.9% based on adapted EPOS criteria. The impact of CRS on sleep quality and daily life activities was significantly higher in uncontrolled versus well-controlled patients. Half of patients had a history of FESS (functional endoscopic sinus surgery) and reported lower symptom severity compared to patients without a history of FESS, except for patients with a history of more than 3 procedures. Patients with a history of FESS reported higher VAS levels for impaired smell. Conclusion Real-life data confirm the high disease burden in uncontrolled CRS patients, clearly impacting quality of life. Sinus surgery improves patient-reported outcomes, but not in patients with a history of more than 3 procedures. Mobile technology opens a new era of real-life monitoring, supporting the evolution of care towards precision medicine. | Document URI: | http://hdl.handle.net/1942/34600 | ISSN: | 0105-4538 | e-ISSN: | 1398-9995 | DOI: | 10.1111/all.14408 | ISI #: | WOS:000566571500001 | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
all14408.pdf | Published version | 1.11 MB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
44
checked on Oct 10, 2024
Page view(s)
48
checked on Sep 7, 2022
Download(s)
12
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.